Free Trial

Anterix (NASDAQ:ATEX) Sets New 1-Year Low - Here's Why

Anterix logo with Computer and Technology background

Anterix Inc. (NASDAQ:ATEX - Get Free Report)'s stock price hit a new 52-week low during trading on Friday . The company traded as low as $27.02 and last traded at $27.10, with a volume of 96760 shares traded. The stock had previously closed at $27.97.

Analyst Ratings Changes

Separately, JPMorgan Chase & Co. raised their target price on shares of Anterix from $61.00 to $67.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th.

Check Out Our Latest Stock Report on Anterix

Anterix Price Performance

The company has a market capitalization of $498.32 million, a PE ratio of -16.45 and a beta of 0.94. The company's fifty day moving average is $31.26 and its 200-day moving average is $32.79.

Hedge Funds Weigh In On Anterix

Several institutional investors have recently bought and sold shares of ATEX. DG Capital Management LLC purchased a new position in Anterix during the fourth quarter valued at approximately $13,158,000. Scoggin Management LP purchased a new position in Anterix in the first quarter worth $10,980,000. Nuveen LLC acquired a new stake in shares of Anterix during the first quarter worth $7,204,000. Roubaix Capital LLC acquired a new stake in shares of Anterix during the first quarter worth $5,918,000. Finally, AYAL Capital Advisors Ltd acquired a new position in Anterix during the first quarter valued at $3,611,000. 87.67% of the stock is owned by hedge funds and other institutional investors.

About Anterix

(Get Free Report)

Anterix Inc operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico.

Featured Articles

Should You Invest $1,000 in Anterix Right Now?

Before you consider Anterix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.

While Anterix currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now
Palantir at All-Time Highs: Take Profits or Hold the Line?
3 Tech Stocks Insiders Are Buying: Speculative Plays for June

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines